Skip to main content

Your search for “Liver fibrosis” returned 47 results

U.S. News & World Report: UC San Diego #1 for Gastroenterology and Hepatology Research

October 28, 2020

U.S. News & World Report named University of California San Diego School of Medicine a top global university and ranked the divisions of Gastroenterology and Hepatology #1 in the world for research.

Organ Transplant Recipients Significantly Protected by COVID-19 Vaccination

August 5, 2021

UC San Diego researchers report that solid organ transplant recipients who were vaccinated experienced an almost 80 percent reduction in the incidence of symptomatic COVID-19 compared to unvaccinated counterparts during the same time.

Stool Microbes Predict Advanced Liver Disease

May 2, 2017

Nonalcoholic fatty liver disease (NAFLD) — a condition that can lead to liver cirrhosis and cancer — isn’t typically detected until well advanced. Even then, diagnosis requires a biopsy. To more easily detect NAFLD, UC San Diego School of Medicine researchers and their collaborators report that the microbial makeup of…

Caspase-2 Enzyme Inhibition Shows Promise for Ameliorating Fatty Liver Disease

September 13, 2018

…driver of non-alcoholic steatohepatitis (NASH), a chronic and aggressive liver condition. By identifying caspase-2’s critical role, they believe an inhibitor of this enzyme could provide an effective way to stop the pathogenic progression that leads to NASH — and possibly even reverse early symptoms.

How to Reset a Diseased Cell

May 1, 2015

In proof-of-concept experiments, researchers at University of California, San Diego School of Medicine demonstrate the ability to tune medically relevant cell behaviors by manipulating a key hub in cell communication networks. The manipulation of this communication node, reported in this week’s issue of Proceedings of the National Academy of Sciences,…

Lung, Heart, Kidney and Liver Transplant Programs Rank among Nation’s Best

January 5, 2021

UC San Diego Health’s lung, heart, kidney and liver transplant programs rank at the top nationally in the latest biannual Scientific Registry of Transplant Recipients (SRTR) report. Innovative treatment and multi-disciplinary care contribute to the high rankings for one-year survival outcomes.

Novel Antisense Drug Shows Promise in Slowing Fatty Liver Disease

June 16, 2020

A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.

UC San Diego to Advance Stem Cell Therapies in New Space Station Lab

April 8, 2020

UC San Diego and Space Tango received a NASA award to develop the first dedicated stem cell research laboratory within the International Space Station.

Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics

July 29, 2015

Tapping the potential of metabolomics, an emerging field focused on the chemical processes of metabolism, researchers at University of California, San Diego School of Medicine have identified a new and pivotal player in diabetic kidney disease.

Study: E-Cigarettes Trigger Inflammation in the Gut

January 7, 2021

Chemicals used for vaping break down zipper-like junctions between cells in the gut, leading to chronic inflammation and potential for other health concerns.

Category navigation with Social links